Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
2(50.0%)
Phase 3
2(50.0%)
4Total
Phase 1(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06348797Phase 1Recruiting

Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC

Role: collaborator

NCT06760455Phase 1Recruiting

A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects

Role: lead

NCT06092684Phase 3Completed

The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery

Role: lead

NCT06339086Phase 3Not Yet Recruiting

Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes

Role: lead

All 4 trials loaded